Document is current
Any future updates will be listed below
-
Authors
Lanshoeft, Christian https://orcid.org/0000-0002-2405-0227
Schütz, Raphael https://orcid.org/0009-0000-6945-9299
Lozac’h, Frédéric https://orcid.org/0000-0003-4911-2807
Schlotterbeck, Götz https://orcid.org/0000-0002-9082-2846
Walles, Markus https://orcid.org/0000-0001-8376-8311
- License Information
-
More Information
Article History
Received: 25 September 2023
Revised: 17 November 2023
Accepted: 20 November 2023
First Online: 2 December 2023
Change Date: 9 December 2023
Change Type: Update
Change Details: Springer Nature’s version of this paper was updated to present the complete Supplementary Files.
Declarations
:
: Both preclinical studies of NVS1 were conducted in compliance with the Animal Welfare Act, the Guide for the Care and Use of Laboratory Animals, and the Office of Laboratory Animal Welfare and in accordance with the Novartis Animal Care and Use Committee (NACUC).
: The authors declare no competing interests.
